ÂÜÀòÂÒÂ×

Kristina Hazard has extensive work experience in the biopharmaceutical industry. Kristina is currently working at Hansa Biopharma as a Principal Scientist, a position they have held since April 2022. Prior to this role, they worked at the same company as a Senior Scientist from September 2018 to April 2022.

Before joining Hansa Biopharma, Kristina worked at Wieslab, a Svar Life Science company, where they held the position of Senior Scientist from February 2016 to September 2018.

In 2009, Kristina started their career at Novo Nordisk, where they held various roles. Kristina began as a Research Scientist from July 2009 to March 2011, where they focused on bioanalytical assay validation and served as a Study Director in clinical projects. Kristina then advanced to the position of Senior Scientist from March 2011 to January 2016, where their responsibilities included bioanalytical assay validation, serving as a Principal Investigator in non-clinical projects, and as a Study Director in clinical projects.

Prior to their industry experience, Kristina worked at Statens Serum Institut as a Senior Research Associate from November 2007 to July 2009.

Kristina's academic background includes a Ph.D. in the field of medical microbiology with emphasis on virology, which they obtained from Lund University from January 2003 to July 2007.

Kristina Hazard completed their Ph. D. in Medical microbiology - virology from Lund University from 2003 to 2007. Prior to that, they obtained their M. Sc. in Biomedical Laboratory Science from Malmö University from 1998 to 2002. Kristina also pursued Chemical engineering at Mälardalen University from 1996 to 1998. In addition, they studied French at the University of Gothenburg in 1995. There is no information available regarding their education at Burgårdens Gymnasium and Utmarksskolan.